Patenting of stem cells.
Investors in any new technology are concerned to protect their investment, a key part of such protection being the availability of patent protection. Stem cells, human embryonic stem cells in particular, are a highly controversial area, and this controversy extends to the patenting of stem cells. In this article, the legal issues affecting patenting of stem cell technology in the USA and Europe are reviewed. The types of patents that have been granted are also considered, as an illustration of the protection that can be obtained. Finally, the overall trends in patent filings are discussed, to identify key aspects of the patent landscape.
Williams
Gareth
G
Marks & Clerk, Cambridge, UK. gwilliams@marks-clerk.com
D005060:Europe; D006801:Humans; D007449:Investments / Q000191:economics; D010330:Patents as Topic / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D013234:Stem Cells / Q000145:classification / Q000166:cytology*; D014481:United States